Overview

Obese Hypertension Study (0954-315)

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This is a 16-week study to evaluate high systolic and diastolic blood pressure following treatment in obese, hypertensive, adult patients.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Hydrochlorothiazide
Losartan